[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341750-105":59,"doc-detail-341750-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","gsdmd-is-associated-with-survival-in-human-breast-cancer-but-does-not-impact-anti-tumor-immunity-in-a-mouse-breast-cancer-model","GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model","","Inflammation shapes cancer development, with chronic inflammation driving progression and resistance while acute inflammation can support protective anti-tumor immunity. Gasdermin D (GSDMD) mediates release of pro-inflammatory cytokines such as IL-1β, yet its cancer role remains unclear. This study shows GSDMD is upregulated across multiple cancers, with higher expression linked to improved survival in primary breast invasive carcinoma, but not liver hepatocellular carcinoma.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/gsdmd-is-associated-with-survival-in-human-breast-cancer-but-does-not-impact-anti-tumor-immunity-in-a-mouse-breast-cancer-model/341750/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/gsdmd-is-associated-with-survival-in-human-breast-cancer-but-does-not-impact-anti-tumor-immunity-in-a-mouse-breast-cancer-model/341750.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-12","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the relationship between GSDMD expression and survival in human breast cancer?","Question",{"text":112,"@type":113},"Higher GSDMD expression correlates with increased survival in primary breast invasive carcinoma (BRCA).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Does loss of GSDMD alter tumor growth or immune responses in the mouse model?",{"text":117,"@type":113},"GSDMD deficiency did not affect tumor growth, immune cell infiltration, or cytokine expression in the tumor microenvironment, except for Cxcl10 upregulation in hepatoma tumors.",{"name":119,"@type":110,"acceptedAnswer":120},"How does GSDMD deficiency respond to innate immune activation by TLR ligands?",{"text":121,"@type":113},"In vitro and in vivo innate immune activation with TLR ligands showed no significant difference between GSDMD-deficient and wild-type mice.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341750,1790187400,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","TYPE Original Research PUBLISHED 19 August 2024  \nDOI 10.3389/fimmu.2024.1396777  \nOPEN ACCESS  \nEDITED BY  \nUday Kishore,  \nUnited Arab Emirates University,  \nUnited Arab Emirates  \nREVIEWED BY David Sarrio,  \nCentro de Investigacio´n Biome´ dica en Red del C´ancer (CIBERONC), Spain  \nZhenbo Tu,  \nBeth Israel Deaconess Medical Center, United States  \n*CORRESPONDENCE Carole Bourquin  \n [carole.bourquin@unige.ch](carole.bourquin@unige.ch)  \n†These authors share senior authorship  \nRECEIVED 06 March 2024  \nACCEPTED 23 July 2024  \nPUBLISHED 19 August 2024  \nCITATION  \nBoersma B, Puddinu V, Huard A, Fauteux-Daniel S, Wirapati P, Guedri S, Tille J-C, McKee T, Pittet M, Palmer G and Bourquin C (2024) GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model.  \nFront. Immunol. 15:1396777 .  \ndoi: 10.3389/fimmu.2024.1396777  \nCOPYRIGHT  \n© 2024 Boersma, Puddinu, Huard,  \nFauteux-Daniel, Wirapati, Guedri, Tille, McKee, Pittet, Palmer and Bourquin. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nGSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model  \nBart Boersma 1,2, Viola Puddinu 1,2, Arnaud Huard 3,4, S´ebastien Fauteux-Daniel 3,4, Pratyaksha Wirapati 4,5, Soﬁa Guedri 1,2, Jean-Christophe Tille 6, Thomas McKee 4,6, Mikael Pittet 4,7,8,9,10, Gaby Palmer 3,4,10†  \nand Carole Bourquin 1,2,7,10,11*†  \n1School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland, 2 Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland,  \n3 Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland,  \n4 Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland, 5Swiss Institute of Bioinformatics, Lausanne, Switzerland, 6 Division of Clinical Pathology, Geneva University Hospitals, Geneva, Switzerland, 7Translational Research Centre in Onco-Hematology (CRTOH), Geneva, Switzerland, 8AGORA Cancer Research Centre Lausanne, Lausanne, Switzerland, 9 Ludwig Institute for Cancer Research, Lausanne, Switzerland, 10Geneva Centre for Inﬂammation Research, University of Geneva, Geneva, Switzerland, 11 Department of Anesthesiology, Pharmacology, Intensive Care and Emergencies, Faculty of Medicine, University of Geneva, Geneva, Switzerland  \nInﬂammation plays a pivotal role in cancer development, with chronic inﬂammation promoting tumor progression and treatment resistance, whereas acute inﬂammatory responses contribute to protective anti-tumor immunity. Gasdermin D (GSDMD) mediates the release of pro-inﬂammatory cytokines such as IL-1b. While the release of IL-1b is directly linked to the progression of several types of cancers, the role of GSDMD in cancer is less clear. In this study, we show that GSDMD expression is upregulated in human breast, kidney, liver, and prostate cancer. Higher GSDMD expression correlated with increased survival in primary breast invasive carcinoma (BRCA), but not in liver hepatocellular carcinoma (LIHC) . In BRCA, but not in LIHC, high GSDMD expression correlated with a myeloid cell signature associated with improved prognosis. To further investigate the role of GSDMD in anticancer immunity, we induced breast cancer and hepatoma tumors in GSDMD-deﬁcient mice. Contrary to our expectations, GSDMD deﬁciency had no effect on tumor growth, immune cell inﬁltration, or cytokine expression in the tumor microenvironment, except for Cxcl10 upregulation in hepatoma tumors. In vi","cbCaivcaa6g39KIw","https://ap.wps.com/l/cbCaivcaa6g39KIw","pdf",3214043,14,"English","# Key findings\n## Clinical correlation of GSDMD expression\n## Effects of GSDMD deficiency in tumor models\n## Innate immune activation with TLR ligands","[{\"question\":\"What is the relationship between GSDMD expression and survival in human breast cancer?\",\"answer\":\"Higher GSDMD expression correlates with increased survival in primary breast invasive carcinoma (BRCA).\"},{\"question\":\"Does loss of GSDMD alter tumor growth or immune responses in the mouse model?\",\"answer\":\"GSDMD deficiency did not affect tumor growth, immune cell infiltration, or cytokine expression in the tumor microenvironment, except for Cxcl10 upregulation in hepatoma tumors.\"},{\"question\":\"How does GSDMD deficiency respond to innate immune activation by TLR ligands?\",\"answer\":\"In vitro and in vivo innate immune activation with TLR ligands showed no significant difference between GSDMD-deficient and wild-type mice.\"}]","GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model | PDF",1790043563,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7f9139c541bd000cff03756b74ebae0.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8817d29658168182e0292f1f2eabcc06.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f56062fd8c662741b9866366081be2d9.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/231b26ae485a6ae18f26be9bbd915217.webp",980,1385]